Jan L Breslow

Title: Jan L Breslow: Innovator in Immunomodulation

Introduction

Jan L Breslow is a prominent inventor based in Scarsdale, NY (US). She has made significant contributions to the field of immunomodulation, particularly in the treatment of autoimmune diseases. With a total of 3 patents, her work has garnered attention for its potential therapeutic applications.

Latest Patents

Breslow's latest patents include innovative compounds designed to inhibit Coagulation Factor XIIa, which plays a crucial role in the coagulation cascade. One of her notable patents is for Pyranopyrazole and pyrazolopyridine immunomodulators. These compounds are disclosed as useful for treating autoimmune diseases by inhibiting Coagulation Factor XIIa in the presence of thrombin and other coagulation factors. Another significant patent involves aminoacylindazole immunomodulators, which also target Coagulation Factor XIIa and are aimed at treating autoimmune diseases.

Career Highlights

Jan L Breslow is affiliated with The Rockefeller University, where she conducts her research and development. Her work is characterized by a strong focus on creating novel therapeutic agents that can address complex autoimmune conditions.

Collaborations

Breslow has collaborated with notable colleagues, including Manish P Ponda and Harold G Selnick, contributing to a rich environment of innovation and research.

Conclusion

Jan L Breslow's contributions to immunomodulation through her patents and research at The Rockefeller University highlight her role as a leading inventor in the field. Her work continues to pave the way for new treatments for autoimmune diseases.